Management of severe bacterial infections and role of the infectious disease specialist: Results of an interview-based survey;Gestione delle infezioni batteriche gravi e ruolo dell'infettivologo. Risultati di un'indagine condotta a mezzo di intervista

Infezioni in Medicina

Volumn 12, Issue 2, 2004, Pages 90-100

  Esposito, Silvano ^a   Leone, Sebastiano ^a   Noviello, Silvana ^a   Ianniello, Filomena ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Inappropriate antimicrobial treatment; Infectious diseases specialist; Severe bacterial infection

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; COMORBIDITY; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; INTERVIEW; MEDICAL SPECIALIST; PATIENT REFERRAL; PRACTICE GUIDELINE; PROGNOSIS; SEPSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

ANESTHESIOLOGY; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BACTERIAL INFECTIONS; COMBINED MODALITY THERAPY; DATA COLLECTION; DISEASE MANAGEMENT; DRUG THERAPY, COMBINATION; GENERAL SURGERY; HEMATOLOGY; HISTAMINE H1 ANTAGONISTS; HUMANS; INTERVIEWS; INTERVIEWS AS TOPIC; ITALY; MEDICINE; PHYSICIAN'S ROLE; SPECIALIZATION; SPECIALTIES, MEDICAL; SURGERY;

EID: 3242733911     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Juthani-Mehta M., Quagliarello V.J. Prognostic scoring systems for infectious disease: their applicability to the care of older adults. Clin. Infect. Dis. 38(5), 692-696, 2004.
2. Kollef M.H. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin. Infect. Dis. 31 (Suppl 4), S131-S138, 2000.
3. Edmond M.B., Ober J.F., Weinbaum D.L. et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin. Infect. Dis. 20(5), 1126-1133, 1995.
4. Husni R.N., Goldstein L.S., Arroliga A.C. et al. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 115(5), 1378-1382, 1999.
5. Schentag J.J., Hyatt J.M., Carr J.R. et al. Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clin. Infect. Dis. 26 (5), 1204-1214, 1998.
6. Owens G., Felts J.A., Spitznagel E.L. ASA physical status classification: a study consistency of ratings. Anesthesiology 49 (4), 239-243, 1978.
7. Knaus W.A., Draper E.A., Wagner E.A., Zimmerman J.E. APACHE II: a severity of disease in classification system. Crit. Care Med. 13(10), 818-829, 1985.
8. B'Erard F., Gandon J. Postoperative wound infections: the influence of ultraviolet irradiation of the operating room and various other factors. Ann. Surg. 160 (suppl. 1), 1-19, 1964.
9. Fine M.J., Auble T.E., Yealy D.M. et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 336 (4), 243-250, 1997.
10. Vales E.C., Abraira V., Sanchez J.C. et al. A predictive model for mortality of bloodstream infections: bedside analysis with the Weibull function. J. Clin. Epidemiol. 55 (6), 563-572, 2002.
11. Esposito S. Le infezioni polmonari. In Le infezioni in chirurgia (Edimes, Eds) 1996, pp 117-129. Pavia.
12. American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy. Am. J. Respir. Crit. Care Med. 163, 1730-1754, 1996.
13. Campbell G.D. Jr, Niederman M.S., Broughton W.A. et al. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement. Am. J. Respir. Crit. Care Med. 153 (5), 1711-1725, 1995.
14. Martin G.S., Mannino D.M., Eaton S. et al. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348 (16), 1546-1554, 2003.
15. Friedman G., Silva E., Vincent J.L. Has the mortality of septic shock changed with time? Crit. Care Med. 26 (12), 2078-2086, 1998.
16. Sepsis:http://www.adam.com/ency/article/ 000666.html7/10/99.
17. Menichetti F. La neutropenia febbrile nel paziente onco-ematologico. In Infezioni nosocomiali ed antibiotico-resistenza (Il Pensiero Scientifico Editore, Eds) 1999, pp 119-125. Roma.
18. Cruciani M., Rampazzo R., Malena M., et al. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. Clin. Infect. Dis. 23 (4), 795-805, 1996.
19. Farthman E.H., Schöffel U. Epidemiology and pathophysiology of intraabdominal infections (IAI). Infection 26 (5), 329-334, 1998.
20. Jansen H.H. Postmortem findings in peritonitis. Leber Magen Darm. 11 (4), 167-173, 1981.
21. Leibovici L., Shraga I., Drucker M., et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J. Intern. Med. 244 (5), 379-386, 1998.
22. Luna C.M., Vujacich P., Niedeman M.S. et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111 (3), 676-685, 1997.
23. Kollef M.H. The importance of appropriate initial antibiotic therapy for hospital-acquired infections. Am. J. Med. 115 (7), 1582-584, 2003.
24. Rello J., Gallego M., Mariscal D. et al. The value of routine microbial investigation in ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 156 (1), 196-200, 1997.
25. MacArthur R.D., Miller M., Albertson T. et al. Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS Trial. Clin. Infect. Dis. 38 (2), 284-288, 2004.
26. Behrendt G., Schneider S., Brodt H.R. et al. Influence of antimicrobial treatment on mortality in septicemia. J. Chemother. 11 (3), 179-186, 1999.
27. Rubin R.J., Harrington C.A., Poon A. et al. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg. Infect. Dis. 5 (1), 9-17, 1999.
28. Ibrahim E.H., Sherman G., Ward S. et al. The influence of inadequate antimicrobial treatment of blood-stream infections on patient outcomes in the ICU setting. Chest 118 (1), 146-155, 2000.
29. National Nosocomial Infections Surveillance (NNIS). System report, data summary from January 1990-May 1999, issued June 1999. Am. J. Infect. Control 27 (6), 520-532, 1999.
30. McGowan J.E. Minimizing antimicrobial resistance: The key role of the Infectious Diseases physician. Clin. Infect. Dis. 38 (7), 939-942, 2004.
31. Montecalvo M.A., Jarvis W.R., Uman J. et al. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann. Intern. Med. 131 (4), 269-272, 1999.
32. White A.C., Atmar R.L., Wilson J. et al. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin. Infect. Dis. 25 (2), 230-239, 1997.
33. Seppala H., Klaukka T., Vuopio-Varkila J. et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in Group A streptococci in Finland. N. Engl. J. Med. 337 (7), 441-446, 1997.
34. Guillemot D., Carbon C., Balkau B., et al. Low dosage and long treatment duration of β-lactam. Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 279, 365-370, 1998.
35. Byl B., Clevenbergh P., Jacobs F. et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin. Infect. Dis. 29 (1), 60-66, 1999.
36. Fowler V.G., Sanders L.L., Sexton D.J. et al. Outcome of Sthaphylococcus aureus bacteremia according to compliance with recommendations of Infectious Disease specialist: Experience with 244 patients. Clin. Infect. Dis. 27 (3), 478-486, 1998.
37. Murthy R. Implementation of strategies to control antimicrobial resistance. Chest 119 (Suppl. 2), 405S-411S, 2001.
38. Classen D.C., Pestotnik S.L., Evans R.S. et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 277 (4), 301-306, 1997.
39. Evans R.S., Classen D.C., Pestotnik S.L. et al. Improving empiric antibiotic selection using computer decision support. Arch. Intern. Med. 154 (8), 878-884, 1994.
40. Solomkin J.S., Mazuski J.E., Baron E.J. et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin. Infect. Dis. 37 (8), 997-1005, 2003.
41. Hughes W.T., Armstrong D., Bodey G.P. et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin. Infect. Dis. 34 (6), 730-751, 2002.